Michael Tolentino
Oprichter bij Aviceda Therapeutics, Inc.
Profiel
Michael Tolentino is the founder of Aviceda Therapeutics, Inc. He currently holds positions as Director at Panther Pharmaceuticals, Inc., Director at Bespoke, Inc., and Co-Chief Operating Officer & Director at Aviceda Ophthalmics, Inc.
Actieve functies van Michael Tolentino
Bedrijven | Functie | Begin |
---|---|---|
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Oprichter | - |
Panther Pharmaceuticals, Inc.
Panther Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Panther Pharmaceuticals, Inc. operates as a biotechnology company. The company is headquartered in Cambridge, MA. | Directeur/Bestuurslid | - |
Bespoke, Inc.
Bespoke, Inc. Packaged SoftwareTechnology Services Bespoke, Inc. sells eyewear and provides assistance to retailers and eyewear brands to improve and expand their reach in the industry. The private company is based in San Francisco, CA. The company offers a virtual try-on feature and precise frame and lens measurements through their scan technology. The company aims to help both in-store and online businesses improve their customer experience and reduce return rates. The company was founded by Eric Varady, who has been the CEO since incorporation. | Directeur/Bestuurslid | - |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Operationeel Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Panther Pharmaceuticals, Inc.
Panther Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Panther Pharmaceuticals, Inc. operates as a biotechnology company. The company is headquartered in Cambridge, MA. | Commercial Services |
Aviceda Therapeutics, Inc.
Aviceda Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aviceda Therapeutics, Inc. is a biotech company which specializes in clinical sciences, clinical research, and drug development. The firm focuses on glyco-immune therapeutics utilizing the Glyco-Code technology platform to address the innate immune system and chronic non-resolving inflammation. The company was founded by Mohamed Genead, Michael Tolentino, Derek Kunimoto, and Christopher Scott and is headquartered in Cambridge, MA. | Commercial Services |
Bespoke, Inc.
Bespoke, Inc. Packaged SoftwareTechnology Services Bespoke, Inc. sells eyewear and provides assistance to retailers and eyewear brands to improve and expand their reach in the industry. The private company is based in San Francisco, CA. The company offers a virtual try-on feature and precise frame and lens measurements through their scan technology. The company aims to help both in-store and online businesses improve their customer experience and reduce return rates. The company was founded by Eric Varady, who has been the CEO since incorporation. | Technology Services |
Aviceda Ophthalmics, Inc.
Aviceda Ophthalmics, Inc. BiotechnologyHealth Technology Part of Aviceda Therapeutics, Inc., Aviceda Ophthalmics, Inc. develops disease-modifying medicines through innovative technology platforms. The company is based in Cambridge, MA. The company was founded in 2019. The CEO is Mohamed A. Genead. | Health Technology |